Clearance kinetics of CD34+ cells from peripheral blood: an independent predictor of hematologic recovery after high-dose chemotherapy and hematopoietic stem cell transplantation

D'Hondt, Lionel;Wuu, J.;André, Marc;van Lerberghe, C.;Symann, Michel;et.al.
(1999) Bone Marrow Transplantation — Vol. 24, n° 5, p. 483-489 (1999)

Files

24132.pdf
  • Restricted Access
  • Adobe PDF
  • 84.54 KB

Details

Authors
  • Author
  • Wuu, J.
    Author
  • André, MarcUCLouvain
    Author
  • van Lerberghe, C.UCLouvain
    Author
  • Guillaume, ThierryUCLouvain
    Author
  • Feyens, Anne MarieUCLouvain
    Author
  • Humblet, YvesUCLouvain
    Author
  • Dromelet, A.UCLouvain
    Author
  • Chatelain, BernardUCLouvain
    Author
  • Longueville, JacquesUCLouvain
    Author
  • D'Hondt, VéroniqueUCLouvain
    Author
  • Symann, MichelUCLouvain
    Author
Show more
Abstract
We measured the concentration of CD34+ cells in peripheral blood (PB) (1/2) h prior to and (1/2), 1, 3, 6, and 12 h following hematopoietic stem cell (HSC) infusion in 34 breast cancer patients treated with high-dose chemotherapy (HDC). The decrease in these concentrations over time enabled us to determine the clearance kinetics of CD34+ cells from PB. The absolute number of CD34+ cells in PB generally peaked at (1/2) h after infusion, then rapidly declined from 1 to 3 h post infusion and continued to fall until 12 h post transplant, but more slowly. In univariate analysis, CD34+cells/kg infused, CFU-GM/kg infused, the CD34+ count at (1/2) h, and the 12-h clearance of CD34+ cells from PB were predictors of hematologic recovery, as were each of the two phases of clearance when the slope was divided into rapid and slow phases (from (1/2) to 3 and from 3 to 12 h post transplant, respectively). We then stratified our population by the number of CD34+ cells/kg infused. In group 1, patients received </=7.5 x 10(6) CD34+ cells/kg; in group 2, >7.5 x 10(6) CD34+ cells/kg. After adjusting for CD34+ cells injected, age, and purged or unpurged graft in multivariate analysis, the 12 h clearance remained a predictor of hematologic recovery in group 1. In addition, the second phase of clearance (from 3 to 12 h after infusion) was an even better predictor than the 12 h clearance. In group 2, however, no statistically significant correlation was observed, even with the number of HSC injected. Results suggest that rapidity of clearance of CD34+cells from PB is an independent indicator of hematologic recovery in patients receiving lower doses of CD34+ cells. When the cell dose injected is over a threshold, PB clearance correlations with hematologic recovery are masked.
Affiliations

Citations

D’Hondt, L., Wuu, J., André, M., van Lerberghe, C., Guillaume, T., Feyens, A. M., Humblet, Y., Dromelet, A., Chatelain, B., Longueville, J., Stewart, F. M., D’Hondt, V., & Symann, M. (1999). Clearance kinetics of CD34+ cells from peripheral blood: an independent predictor of hematologic recovery after high-dose chemotherapy and hematopoietic stem cell transplantation. Bone Marrow Transplantation, 24(5), 483-489. https://doi.org/10.1038/sj.bmt.1701934 (Original work published 1999)